References
- Ogbonnaya KI, Arem R. Diabetic diarrhea: pathophysiology, diagnosis, and management. Arch Intern Med 1990;150:262-267. https://doi.org/10.1001/archinte.1990.00390140018005
- Gershon MD. Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther 1999;13 Suppl 2:15-30. https://doi.org/10.1046/j.1365-2036.1999.00437.x
- Cremonini F, Delgado-Aros S, Camilleri M. Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil 2003;15:79-86. https://doi.org/10.1046/j.1365-2982.2003.00389.x
- Bossi A, Baresi A, Ballini A, Bindelli C. Ondasentron in the treatment of diabetic diarrhea. Diabetes Care 1994;17:453-454.
- Murao S, Hosokawa H. Serotonin 5-HT3 receptor antagonist for treatment of severe diabetic diarrhea. Diabetes Care 2010;33:e38. https://doi.org/10.2337/dc09-2131
Cited by
- Is Ramosetron Really Useful to Treat Diabetic Diarrhea With Rapid Small Bowel Transit? vol.19, pp.2, 2013, https://doi.org/10.5056/jnm.2013.19.2.270
- Diabetes Mellitus and the Colon vol.15, pp.4, 2013, https://doi.org/10.1007/s11938-017-0151-1
- Diabetes and the Small Intestine vol.15, pp.4, 2013, https://doi.org/10.1007/s11938-017-0155-x
- Diabetes-induced mechanophysiological changes in the small intestine and colon vol.8, pp.6, 2013, https://doi.org/10.4239/wjd.v8.i6.249